The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis
Open Access
- 3 June 2022
- journal article
- review article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (7) , e24534
Abstract
Background: The Coronavirus Disease 2019 (COVID‐19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which has now become a global pandemic owing to its high transmissibility. The SARS‐CoV‐2 nucleocapsid protein tests are playing an important role in screening and diagnosing patients with COVID‐19, and studies about the utility of SARS‐CoV‐2 nucleocapsid protein tests are increasing now.Methods: In this review, all the relevant original studies were assessed by searching in electronic databases including Scopus, Pubmed, Embase, and Web of Science. “SARS‐CoV‐2”, “COVID‐19”, “nucleocapsid protein”, and “antigen detection” were used as keywords.Results: In this review, we summarized the utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis. Among the representative researches, this review analyzed, the sensitivity of SARS‐CoV‐2 nucleocapsid protein detection varies from 13% to 87.9%, while the specificity could almost reach 100% in most studies. As a matter of fact, the sensitivity is around 50% and could be higher or lower due to the influential factors.Conclusion: It is well suggested that SARS‐CoV‐2 nucleocapsid protein is a convenient method with a short turnaround time of about half an hour, and the presence of N antigen is positively related to viral transmissibility, indicating that SARS‐CoV‐2 N protein immunoassays contribute to finding out those infected people rapidly and segregating them from the uninfected people.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFE0204500)
This publication has 39 references indexed in Scilit:
- Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe DiseaseClinical Chemistry, 2020
- Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patientsInternational Journal of Infectious Diseases, 2020
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approachBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Emergence of genomic diversity and recurrent mutations in SARS-CoV-2Infection, Genetics and Evolution, 2020
- Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive reviewJournal of Medical Virology, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- A proposed role for the SARS‐CoV‐2 nucleocapsid protein in the formation and regulation of biomolecular condensatesThe FASEB Journal, 2020
- Biochemical characterization of SARS-CoV-2 nucleocapsid proteinBiochemical and Biophysical Research Communications, 2020
- Coronavirus Disease 2019: Coronaviruses and Blood SafetyTransfusion Medicine Reviews, 2020
- RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreakEmerging Microbes & Infections, 2020